Literature DB >> 175398

Clinical applications of cell surface markers.

M F Greaves.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 175398

Source DB:  PubMed          Journal:  Prog Hematol        ISSN: 0079-6301


× No keyword cloud information.
  9 in total

Review 1.  Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors:  J Lilleyman
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Recent progress in the immunological characterization of leukaemic cells.

Authors:  M F Greaves
Journal:  Blut       Date:  1977-05

3.  Identification of cells expressing T and p28,33 (Ia-like) antigens in sections of human lymphoid tissue.

Authors:  G J Seymour; M F Greaves; G Janossy
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

4.  Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.

Authors:  Y Reisner; M Biniaminov; E Rosenthal; N Sharon; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

5.  Cancer antigens are expressed in a carcinogen-transformed Bloom syndrome B-lymphoblastoid cell line.

Authors:  Y Shiraishi; H Soma
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.

Authors:  R C Williams; G R Hughes; M L Snaith; H F Parry; E Diao; M F Greaves
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

Review 7.  Enzyme and membrane markers in leukaemia: recent developments.

Authors:  A V Hoffbrand; G Janossy
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

8.  Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.

Authors:  L Tupchong; I C MacLennan
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

9.  Characterization of gangliosides in human leucocytes.

Authors:  A Tsuboyama; F Takaku; S Sakamoto; Y Kano; T Ariga; T Miyatake
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.